MoneyWorks4Me

Dr Reddys Laboratories informs about press release

29 Jan 2016 Evaluate

Dr Reddys Laboratories has informed about a press release dated January 29, 2016 titled ‘Dr. Reddy’s Laboratories Receives FDA approval for ZEMBRACE SymTouch (sumatriptan succinate) Injection for the acute treatment of migraines in adults’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1743.00
Dr. Reddys Labs. 1303.00
Cipla 1353.00
Lupin 1950.00
Zydus Lifesciences 1158.10
View more..